MedPath

Pharmaceutical Companies

Savara Pharmaceuticals

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$711M
Website
-

Applied Therapeutics Inc

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$705.1M
Website
-
Wave Life Sciences logo

Wave Life Sciences

πŸ‡ΈπŸ‡¬Singapore
Ownership
Public
Established
2012-01-01
Employees
268
Market Cap
$704.7M
Website
http://www.wavelifesciences.com
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas....
Oric Pharmaceuticals logo

Oric Pharmaceuticals

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2014-01-01
Employees
100
Market Cap
$704.7M
Website
http://www.oricpharma.com
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor...

Travere Therapeutics

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
-
Market Cap
$693M
Website
-
Corbus Pharmaceuticals, Inc. logo

Corbus Pharmaceuticals, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Subsidiary
Established
-
Employees
1
Market Cap
$689.3M
Website
http://www.corbuspharma.com
REVANCE THERAPEUTICS LTD logo

REVANCE THERAPEUTICS LTD

πŸ‡¬πŸ‡§United Kingdom
Ownership
Public
Established
2002-01-01
Employees
597
Market Cap
$685.5M
Website
http://www.revance.com
Alumis, Inc. logo

Alumis, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Public
Established
2021-01-01
Employees
11
Market Cap
$685.4M
Website
http://www.alumis.com

ADAPTOGENICS HEALT

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Established
-
Employees
709
Market Cap
$684.2M
Website
-
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and...

Replimune, Inc.

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Subsidiary
Established
-
Employees
-
Market Cap
$682.5M
Website
-
Β© Copyright 2025. All Rights Reserved by MedPath